| Schedule of Earnings Per Share |
The
following table sets forth the computation of the Company’s basic and diluted net income (loss) per share (unaudited) during the
three months ended March 31, 2023 and 2022:
Schedule of Earnings Per Share
| |
|
2023 |
|
|
2022 |
|
| |
|
Three Months Ended March 31, |
|
| |
|
2023 |
|
|
2022 |
|
| Numerator |
|
|
|
|
|
|
| Net income (loss) from continuing operations |
|
$ |
805,560 |
|
|
$ |
(2,266,132 |
) |
| Deemed dividends |
|
|
- |
|
|
|
(135,924,745 |
) |
| Net income (loss) available to common stockholders, continuing operations |
|
|
805,560 |
|
|
|
(138,190,877 |
) |
| Net loss from discontinued operations |
|
|
- |
|
|
|
(1,434 |
) |
| Net income (loss) available to common stockholders |
|
$ |
805,560 |
|
|
$ |
(138,192,311 |
) |
| |
|
|
|
|
|
|
|
|
| Denominator |
|
|
|
|
|
|
|
|
| Weighted average number of shares of common stock outstanding during the period
– basic |
|
|
29,754,877,813 |
|
|
|
4,812,754 |
|
| Warrants |
|
|
27,733,334,296 |
|
|
|
- |
|
| Preferred stock |
|
|
452,324,855,556 |
|
|
|
- |
|
| Weighted average number of shares of common stock and common stock equivalents
outstanding during the period - diluted |
|
|
509,813,067,665 |
|
|
|
4,812,754 |
|
| |
|
|
|
|
|
|
|
|
| Net income (loss) per share of common stock available to common stockholders – basic and diluted: |
|
|
|
|
|
|
|
|
| Continuing operations |
|
$ |
0.00 |
|
|
$ |
(28.71 |
) |
| Discontinued operations |
|
|
- |
|
|
|
(0.00 |
) |
| Total |
|
$ |
0.00 |
|
|
$ |
(28.71 |
) |
|
| Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share |
Diluted
income (loss) per share excludes all dilutive potential shares if their effect is anti-dilutive. As of March 31, 2023 and 2022, the following
potential common stock equivalents were excluded from the calculation of diluted income (loss) per share as their effect was anti-dilutive:
Schedule of Anti-dilutive Securities Excluded from Computation of
Earnings Per Share
| |
|
2023 |
|
|
2022 |
|
| |
|
Three Months Ended March 31, |
|
| |
|
2023 |
|
|
2022 |
|
| Common stock warrants |
|
|
483,600,016,793 |
|
|
|
5,002,174,096 |
|
| Convertible preferred stock |
|
|
- |
|
|
|
3,093,872,894 |
|
| Convertible debentures |
|
|
28,777,833,333 |
|
|
|
388,960,870 |
|
| Stock options |
|
|
26 |
|
|
|
26 |
|
|
Anti-dilutive
shares
|
|
|
512,377,850,152 |
|
|
|
8,485,007,886 |
|
|